Davide Leone & Partners Investment CO Ltd. Allakos Inc. Put Options Transaction History

Davide Leone & Partners Investment CO Ltd.

$0
Q3 2024

Put Options

0 transactions

Quarter	Operation	Price Per put	puts change	puts Held	SEC Form

No transaction found.

Others Institutions Holding ALLK

# of Institutions

Shares Held

64.7M

Call Options Held

47.1K

Put Options Held

Bvf Inc San Francisco, CA

16.6M
Shares

$21.5 Million
0.34% of portfolio
Nea Management Company, LLC Timonium, MD

6.15M
Shares

$7.99 Million
0.31% of portfolio
Deep Track Capital, LP Greenwich, CT

5M
Shares

$6.5 Million
0.12% of portfolio
Vanguard Group Inc Valley Forge, PA

3.51M
Shares

$4.57 Million
0.0% of portfolio
Redmile Group, LLC San Francisco, CA

3.08M
Shares

$4 Million
0.13% of portfolio

View Full List

About Allakos Inc.

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $110M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

More about ALLK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Davide Leone & Partners Investment CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Davide Leone & Partners Investment CO Ltd. with notifications on news.

Account